• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用散射免疫比浊法测定血清糖化转铁蛋白在鉴别诊断酒精性和非酒精性肝病中的应用。

Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases.

机构信息

Divisions of Clinical Mass Spectrometry and Clinical Genetics, Chiba University Hospital, Chiba, Japan.

Department of Gastroenterology and Hepatology, Nihon University School of Medicine, Tokyo, Japan.

出版信息

Clin Chim Acta. 2018 Oct;485:181-186. doi: 10.1016/j.cca.2018.06.040. Epub 2018 Jun 27.

DOI:10.1016/j.cca.2018.06.040
PMID:29958893
Abstract

BACKGROUND

Carbohydrate-deficient transferrin is a biological marker of excessive drinking. The aim of this study was to evaluate the diagnostic value of a direct nephelometric immunoassay for the differential diagnosis of alcoholic and non-alcoholic liver diseases in comparison with gamma glutamyl transferase.

METHODS

Serum samples were obtained from 305 subjects, including 122 patients with alcoholic and 102 cases with non-alcoholic liver diseases. Serum levels of carbohydrate-deficient transferrin were expressed as a percentage of total transferrin.

RESULTS

Serum % carbohydrate-deficient transferrin levels were significantly higher in patients with alcoholic than with non-alcoholic liver diseases. Carbohydrate-deficient transferrin had better specificity than gamma glutamyl transferase to differentiate between alcoholic and non-alcoholic liver diseases.There were 8 alcoholic liver disease patients with normal gamma glutamyl transferase levels, and carbohydrate-deficient transferrin was significantly elevated in 6 of them. On the other hand, there were 25 non-alcoholic liver disease patients with elevated gamma glutamyl transferase levels; their carbohydrate-deficient transferrin levels were within the reference intervals in all cases.

CONCLUSION

This simple carbohydrate-deficient transferrin immunoassay is useful to detect so-called gamma glutamyl transferase non-responding drinkers and also to exclude the possible role of excessive drinking in apparently non-alcoholic liver diseases. A large-scale prospective study is needed to further confirm the diagnostic utility of carbohydrate-deficient transferrin.

摘要

背景

糖缺乏转铁蛋白是过量饮酒的生物标志物。本研究旨在评估直接散射免疫比浊法在鉴别诊断酒精性和非酒精性肝病方面的诊断价值,并与γ-谷氨酰转移酶进行比较。

方法

从 305 名受试者中获得血清样本,包括 122 例酒精性肝病患者和 102 例非酒精性肝病患者。血清糖缺乏转铁蛋白水平以总转铁蛋白的百分比表示。

结果

酒精性肝病患者的血清 %糖缺乏转铁蛋白水平明显高于非酒精性肝病患者。糖缺乏转铁蛋白在鉴别酒精性和非酒精性肝病方面的特异性优于γ-谷氨酰转移酶。有 8 例酒精性肝病患者的γ-谷氨酰转移酶水平正常,其中 6 例糖缺乏转铁蛋白明显升高。另一方面,有 25 例非酒精性肝病患者的γ-谷氨酰转移酶水平升高;他们的糖缺乏转铁蛋白水平在所有情况下均在参考区间内。

结论

这种简单的糖缺乏转铁蛋白免疫测定法可用于检测所谓的γ-谷氨酰转移酶无应答饮酒者,并排除过量饮酒在明显非酒精性肝病中的可能作用。需要进行大规模前瞻性研究以进一步证实糖缺乏转铁蛋白的诊断效用。

相似文献

1
Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases.采用散射免疫比浊法测定血清糖化转铁蛋白在鉴别诊断酒精性和非酒精性肝病中的应用。
Clin Chim Acta. 2018 Oct;485:181-186. doi: 10.1016/j.cca.2018.06.040. Epub 2018 Jun 27.
2
A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit.
J Hepatol. 1997 Dec;27(6):1003-8. doi: 10.1016/s0168-8278(97)80143-2.
3
Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.碳水化合物缺乏转铁蛋白(%CDT)、γ-谷氨酰转移酶(γ-GT)和平均红细胞体积(MCV)作为慢性酒精滥用生物标志物的有效性:一项针对酒精依赖患者以及非酒精性和酒精性肝病患者的研究
Addiction. 2005 Oct;100(10):1477-86. doi: 10.1111/j.1360-0443.2005.01216.x.
4
Carbohydrate-deficient transferrin and gamma-glutamyl transpeptidase in the evaluation of alcohol consumption. A five-year retrospective study of 633 outpatients in a single center.
Gastroenterol Clin Biol. 2005 Feb;29(2):113-6. doi: 10.1016/s0399-8320(05)80712-2.
5
Carbohydrate-deficient transferrin as a screening marker for drinking in a general hospital population.
Alcohol Alcohol. 1996 May;31(3):249-56. doi: 10.1093/oxfordjournals.alcalc.a008144.
6
Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.评估去糖基转铁蛋白用于检测肝功能不全患者酒精滥用情况。
Alcohol Alcohol. 1995 Mar;30(2):171-6.
7
[Carbohydrate-deficient transferrin and liver diseases. Study of 94 patients].[缺糖转铁蛋白与肝脏疾病。94例患者的研究]
Gastroenterol Clin Biol. 1995 Aug-Sep;19(8-9):698-702.
8
Carbohydrate deficient transferrin: a marker for alcohol abuse.
BMJ. 1989 Aug 12;299(6696):427-31. doi: 10.1136/bmj.299.6696.427.
9
Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.相对与绝对碳水化合物缺乏转铁蛋白作为急性酒精性肝炎患者酒精摄入量标志物的研究
Alcohol Clin Exp Res. 1999 Oct;23(10):1614-8.
10
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease.碳水化合物缺乏转铁蛋白是脂肪性肝病患者饮酒的敏感标志物。
Hepatol Int. 2022 Apr;16(2):348-358. doi: 10.1007/s12072-022-10298-8. Epub 2022 Jan 20.

引用本文的文献

1
Utilizing %Carbohydrate-deficient Transferrin as a Biomarker to Complement Interviews in Stratifying Alcohol Consumption in Patients with Alcohol Dependence: Aiming for Application to Fatty Liver Disease.利用缺糖转铁蛋白作为生物标志物以辅助访谈对酒精依赖患者的酒精摄入量进行分层:旨在应用于脂肪肝疾病
JMA J. 2025 Jul 15;8(3):885-892. doi: 10.31662/jmaj.2025-0109. Epub 2025 Jun 13.
2
Alcoholic vs. Nonalcoholic Steatohepatitis: Vascular Branching Heterogeneity on Magnetic Resonance Imaging as a Diagnostic Marker.酒精性与非酒精性脂肪性肝炎:磁共振成像上的血管分支异质性作为一种诊断标志物
J Clin Transl Hepatol. 2023 Jun 28;11(3):534-539. doi: 10.14218/JCTH.2022.00279. Epub 2023 Jan 10.
3
Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets.
酒精性肝病中的铁过载:潜在机制、有害影响和潜在治疗靶点。
Cell Mol Life Sci. 2022 Mar 24;79(4):201. doi: 10.1007/s00018-022-04239-9.
4
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation.临床糖组学中的质谱分析:从生物标志物鉴定到临床应用的历程。
Clin Mass Spectrom. 2020 Aug 27;18:1-12. doi: 10.1016/j.clinms.2020.08.001. eCollection 2020 Nov.